ANIX (Anixa Biosciences, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by ANIX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-03 | AMIT KUMAR | Chief Executive Officer | Buy | — | — |
| 2026-07-29 | Arnold M Baskies | Director | MIXED | — | — |
| 2026-07-28 | AMIT KUMAR | Chief Executive Officer | Buy | — | — |
| 2026-07-27 | AMIT KUMAR | Chief Executive Officer | Buy | — | — |
| 2026-07-27 | AMIT KUMAR | Chief Executive Officer | Buy | — | — |
| 2026-07-21 | AMIT KUMAR | Chief Executive Officer | Buy | — | — |
| 2026-07-20 | Lewis H jr Titterton | Director | Buy | — | — |
| 2026-07-16 | Lewis H jr Titterton | Director | Buy | — | — |
| 2026-07-13 | AMIT KUMAR | Chief Executive Officer | Buy | — | — |
| 2026-06-17 | Lewis H jr Titterton | Director | Buy | — | — |
| 2026-06-16 | AMIT KUMAR | Chief Executive Officer | Buy | — | — |
| 2026-01-29 | Arnold M Baskies | Director | Buy | — | — |
| 2026-01-06 | Emily Gottschalk | Director | A | — | — |
| 2026-01-06 | AMIT KUMAR | Chief Executive Officer | A | — | — |
| 2026-01-06 | Lewis H jr Titterton | Director | A | — | — |
| 2026-01-06 | Michael Catelani | President, COO & CFO | A | — | — |
| 2026-01-06 | Arnold M Baskies | Director | A | — | — |
| 2025-12-16 | Lewis H jr Titterton | Director | M | — | — |
| 2025-10-31 | AMIT KUMAR | Chief Executive Officer | MIXED | — | — |
| 2025-08-04 | Lewis H jr Titterton | Director | Buy | — | — |
| 2025-07-31 | AMIT KUMAR | Chief Executive Officer | Buy | — | — |
| 2025-07-21 | Arnold M Baskies | Director | Buy | — | — |
| 2025-07-15 | Lewis H jr Titterton | Director | Buy | — | — |
| 2025-07-14 | AMIT KUMAR | Chief Executive Officer | Buy | — | — |
| 2025-06-05 | AMIT KUMAR | Chief Executive Officer | Buy | — | — |
| 2025-01-29 | Arnold M Baskies | Director | Buy | — | — |
| 2025-01-27 | Lewis H jr Titterton | Director | Buy | — | — |
| 2025-01-23 | Lewis H jr Titterton | Director | Buy | — | — |
| 2025-01-22 | Lewis H jr Titterton | Director | Buy | — | — |
| 2025-01-17 | Lewis H jr Titterton | Director | Buy | — | — |
| 2025-01-15 | Michael Catelani | President, COO, & CFO | Buy | — | — |
| 2025-01-15 | AMIT KUMAR | Chief Executive Officer | Buy | — | — |
| 2025-01-03 | Lewis H jr Titterton | Director | A | — | — |
| 2025-01-03 | Arnold M Baskies | Director | A | — | — |
| 2025-01-03 | Emily Gottschalk | Director | A | — | — |
| 2025-01-03 | AMIT KUMAR | Chief Executive Officer | A | — | — |
| 2025-01-03 | Michael Catelani | President, COO & CFO | A | — | — |
| 2024-10-23 | Lewis H jr Titterton | Director | M | — | — |
| 2024-08-01 | Lewis H jr Titterton | Director | Buy | — | — |
| 2024-07-29 | Lewis H jr Titterton | Director | Buy | — | — |
| 2024-07-26 | Arnold M Baskies | Director | Buy | — | — |
| 2024-06-18 | Lewis H jr Titterton | Director | Buy | — | — |
| 2024-06-14 | Lewis H jr Titterton | Director | Buy | — | — |
| 2024-06-12 | Lewis H jr Titterton | Director | Buy | — | — |
| 2024-06-10 | Lewis H jr Titterton | Director | Buy | — | — |
| 2024-06-07 | Michael Catelani | President, COO, & CFO | Buy | — | — |
| 2024-06-07 | AMIT KUMAR | Chief Executive Officer | Buy | — | — |
| 2024-05-02 | Michael Catelani | President, COO, & CFO | A | — | — |
| 2024-04-10 | Lewis H jr Titterton | Director | Buy | — | — |
| 2024-03-15 | AMIT KUMAR | Chief Executive Officer | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 986,967 | — |
| — | Chief Executive Officer | 657,000 | — |
| — | Director | 141,000 | — |
| — | Director | 50,900 | — |
| — | Director | 45,665 | — |
| — | President, COO & CFO | 44,500 | — |
| — | Director | 2,000 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ANIX quote page; the site-wide leaderboard is on the insider transactions hub.